tiprankstipranks
Santen Pharmaceutical Co Ltd (SNPHF)
OTHER OTC:SNPHF
Holding SNPHF?
Track your performance easily

Santen Pharmaceutical Co (SNPHF) Cash flow

6 Followers

Santen Pharmaceutical Co Cash Flow

SNPHF's free cash flow for Q3 2022 was ¥5.41B. For the 2022 fiscal year, SNPHF's free cash flow was decreased by ¥-10.20B and operating cash flow was ¥10.15B. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Operating Cash Flow
¥ 43.34B-¥ 46.04B¥ 38.81B¥ 39.95B¥ 32.89B
Investing Cash Flow
¥ -35.53B-¥ -35.17B¥ -53.35B¥ -5.17B¥ -2.94B
Financing Cash Flow
¥ -18.29B-¥ 5.56B¥ -16.68B¥ -12.73B¥ -28.11B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
¥ 281.95B-¥ 83.01B¥ 62.89B¥ 91.43B¥ 70.80B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
¥ 10.53B-¥ 20.46B¥ 307.00M¥ 1.48B¥ 567.00M
Repayment Of Debt
¥ -145.00M-¥ 0.00¥ -3.00B¥ -500.00M¥ -4.10B
Free Cash Flow
¥ 7.35B-¥ 10.20B¥ 15.00B¥ 30.72B¥ 24.56B
Domestic Sales
------
Foreign Sales
------
Currency in JPY

Santen Pharmaceutical Co Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis